| 000 | 01003 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250517234210.0 | ||
| 264 | 0 | _c20181211 | |
| 008 | 201812s 0 0 eng d | ||
| 022 | _a2376-1032 | ||
| 024 | 7 |
_a10.18553/jmcp.2018.24.9-a.s3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMcGill, Janet | |
| 245 | 0 | 0 |
_aIntroduction. _h[electronic resource] |
| 260 |
_bJournal of managed care & specialty pharmacy _cSep 2018 |
||
| 300 |
_aS3-S4 p. _bdigital |
||
| 500 | _aPublication Type: Introductory Journal Article | ||
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 |
_aGlucagon-Like Peptide 1 _xagonists |
| 650 | 0 | 4 |
_aGlucagon-Like Peptide-1 Receptor _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
| 650 | 0 | 4 | _aGlucagon-Like Peptide-1 Receptor Agonists |
| 773 | 0 |
_tJournal of managed care & specialty pharmacy _gvol. 24 _gno. 9-a Suppl _gp. S3-S4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.18553/jmcp.2018.24.9-a.s3 _zAvailable from publisher's website |
| 999 |
_c28777660 _d28777660 |
||